Ligence soon to automate cardiac ultrasound imaging
Lithuania is becoming a growth hotspot for digital health as the Life Sciences sector here is regarded as one of the most highly developed in Central and Eastern Europe. Life…
Read more
LIFE SCIENCE
The annual growth of the Lithuanian life sciences sector is 19%, which is one of the most rapid growth paces across the European Union. Lithuania’s potential is defined by well-developed infrastructure, universities and research centers, growing industry, significant foreign investments and national strategic directions.
Health technologies
Lithuania has been gradually becoming one of the high tech centers in the region. 90% of Lithuanian biotechnological, pharmaceutical products and medical devices are exported globally. LBTA represent as Lithuanian Health Technology Ecosystem within ECH Alliance global network.
Bioeconomy
Bioeconomy is a part of economy that produce renewable raw materials (biomass) and processes these raw materials and biowaste into value-added products – food, feed, industrial products, bioenergy. LBTA participates in national bioeconomy strategy development and implementation.
I think the biggest innovations of the 21st century
will be at the intersection of biology and technology. A new era is beginning.
– Steve Jobs, 2011 m.
0
MEMBER COMPANIES
0
ACADEMIA
0
HONORABLE MEMBERS
0
PERSONAL MEMBERS
Newsroom
Another member has joined the association – Santaros klinikos Biobank ‘We are open for the new partnerships’
We also would like to congratulate another member of our association – Santaros klinikos Biobank! Santaros klinikos Biobank’s main priority is to provide access of large variety standardized and systematized…
“Cureline Baltics“ – another member of the US business community, joined to the Lithuanian life sciences sector
“Cureline“ a US-based company, is one of the world’s leading biomedical research communities. The company conducts its core business from its headquarters in California. “Cureline“ collaborating with the world’s leading…
The pandemic left no scars: Lithuanian biotech sector grew at its fastest last year of the past decade
Last year, Lithuania’s biotechnology sector grew by almost 87%. Businesses in the sector generated revenues of close to €2 billion and contributed around 2.5% to the country’s GDP. One employee…
“Imunodiagnostika” recently became a member of LBTA – company that focuses on innovative in-vitro diagnostics solutions in the field of immunology
JSC „Imunodiagnostika“ was established in 2013 with the purpose to realize the long-term experience in various allergic disease diagnostics into the innovative IVD products. With constantly improving diagnostic technologies, we…
LBTA is growing this summer – our first new addition Ligence team
Ligence was founded by a team of medical practitioners aiming to deliver artificial intelligence solutions for everyday cardiologists work. Currently, it requires a trained and experienced specialist to accurately perform…